OTC · Financial Statements
Molecular Templates, Inc. (MTEM) Financial Statements
$0.00
OTC: MTEM
Market Cap $658
Overview Financials Dividend Molecular Templates, Inc. most recently reported annual revenue of $57.0M, a net loss of $8.0M. Revenue grew at an average annual rate of 34.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $22.0M $19.0M $39.0M $20.0M $57.0M Operating Profit $-70.0M $-101.0M $-80.0M $-89.0M $-10.0M Net Profit $-69.0M $-105.0M $-83.0M $-93.0M $-8.0M EPS $-27.62 $-33.06 $-22.50 $-24.75 $-1.80 Op Margin -316.3% -535.1% -206.9% -449.9% -18.3%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $174.0M $140.0M $192.0M $98.0M $35.0M Total Liabilities $71.0M $81.0M $127.0M $113.0M $31.0M Cash $85.0M $25.0M $25.0M $32.0M $12.0M Borrowings $17.0M $27.0M $45.0M $51.0M $12.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-25.0M $-84.0M $-30.0M $-89.0M $-42.0M Investing Cash Flow $-49.0M $-69.0M $-66.0M $92.0M $29.0M Financing Cash Flow $2.0M $1.0M $2.0M $0 $0 Net Cash Flow $1.0M $-60.0M $0 $6.0M $-22.0M Free Cash Flow $-35.0M $-91.0M $-34.0M $-92.0M $-42.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.61 FCF Yield -6386018.24% Quick Ratio 0.97 Interest Coverage -3.94 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .